Zobrazeno 1 - 10
of 16
pro vyhledávání: '"S. L. Jindal"'
Publikováno v:
Tissue Antigens. 26:168-171
Publikováno v:
Drug Safety. 5:168
Autor:
Robert W. Murray, S. L. Jindal
Publikováno v:
Photochemistry and Photobiology. 16:147-151
Publikováno v:
Vox Sanguinis. 36:353-355
The HLA typing of hemodialysis patients and normal subjects suggests a negative association of B8 and positive association of B5 with the development of anti-HBs and a negative association of BW35 with HBsAg antigenemia.
Publikováno v:
Canadian journal of surgery. Journal canadien de chirurgie. 24(2)
The authors present the seventh reported case of bilateral renal cell carcinoma in polycystic kidneys. They review the literature on benign and malignant tumours in polycystic kidneys emphasizing the diagnostic problems created by this condition. The
Publikováno v:
Transplantation proceedings. 11(1)
One and two-year allograft survival rates of 117 first and 20 second consecutive cadaveric renal allografts are analyzed. The following observations were made: (1) Pretransplant blood transfusions may not improve rate of allograft survival per se. (2
Publikováno v:
Methods in enzymology. 62
Autor:
E Z, Rabin, S L, Jindal, G A, Posen, B, Tattrie, D, Algom, D A, Roncari, M, Freedman, E F, Saunders
Publikováno v:
Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association. 14
The normal level of serum or plasma poly C-avid ribonuclease activity is 1047 +/- 247 U/mL. Serum levels increase proportionately with elevations in serum creatinine, reaching levels of 9,500-35,000 in patients undergoing dialysis. The levels can be
Publikováno v:
Transplantation proceedings. 21(2)
Although the risk of HBsAg infection has now been reduced significantly by screening of blood, isolation of HBsAg+ patients, and more recently by vaccination, transplant-eligible patients can still be seen. We observed an increased mortality in HBsAg
Publikováno v:
Transplantation proceedings. 21(2)
Class II HLA matching, especially HLA-DQ and DR, significantly improved allograft survival. HLA-DQ and DR matching may also be associated, in general, with a quiescent posttransplantation course, reduced incidence of SRRE, and somewhat better respons